revolving doors

Pages

 

CEO reviews recent developments in the Commission's approach to the revolving door.

A Corporate Europe Observatory complaint to the lobby register secretariat is challenging the Commission to properly implement its own lobby transparency rules. 

After a decade of lobby scandals and debate on how to secure transparency and ethics, the European Commission needs to go beyond half measures.

The way in which the Commission has appointed the head of its “in-house think-tank” has demonstrated its woefully inadequate conflict of interest assessment for new appointments, says Corporate Europe Observatory. The conflict of interest assessment applied to the former chief of the Lisbon Council, Ann Mettler as head of the new European Political Strategy Center (EPSC) does not appear to have explored her close cooperation with some of the biggest corporate players in the digital and technology market. In CEO's view, this casts serious doubts on the independence of the advice that is to be given to President Juncker and his college of commissioners.

Subscribe to our newsletter

CEO welcomes the very strongly worded final ruling by European Ombudsman Emily O'Reilly in her inquiry into the Commission's implementation of UN rules for contacts with tobacco industry lobbyists.

CEO joined forces with nine other civil society organisations working for equality, non-discrimination, transparent decision-making and strong ethics rules: in an open letter to the European Parliament we urge MEPs to oppose Oettinger’s appointment as the Comission’s head of human resources.

After nine months of hearings, the draft report of the EU Parliament's inquiry into the Dieselgate scandal has it black on white: the European Commission and EU member states had known since 2004-05 that diesel cars' nitrogen oxide emissions were far above legal limits - yet neither took action.

Our new report shows how industry lobbies present employee protection against work-related cancers as an 'unnecessary' burden on companies, and explains which tactics have been used to weaken and delay the European Union's revision of the Carcinogens and Mutagens Directive.